Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 20, 2024 - Issue 1
Submit an article Journal homepage
0
Views
0
CrossRef citations to date
0
Altmetric
Immunotherapy - Cancer

Combining iRGD with HuFOLactis enhances antitumor potency by facilitating immune cell infiltration and activation

Jie Shaoa Department of Oncology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, ChinaView further author information
,
Kai Xinb Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School，Nanjing University, Nanjing, ChinaView further author information
,
Zhaoye Qianc Department of Oncology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, ChinaView further author information
,
Fangcen Liud Department of Pathology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School，Nanjing University, Nanjing, ChinaView further author information
,
Lin Lia Department of Oncology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, ChinaView further author information
,
Junmeng Zhub Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School，Nanjing University, Nanjing, ChinaView further author information
,
Qin Liub Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School，Nanjing University, Nanjing, ChinaView further author information
,
Manman Tianb Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School，Nanjing University, Nanjing, ChinaView further author information
&
Baorui Liua Department of Oncology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China;b Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School，Nanjing University, Nanjing, China;c Department of Oncology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2375825 | Received 11 Oct 2023, Accepted 01 Jul 2024, Published online: 05 Aug 2024

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.